Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS

BACKGROUND: We compared efficacy and treatment persistence in treatment-naive patients with relapsing-remitting multiple sclerosis (RRMS) initiating natalizumab compared with interferon-β (IFN-β)/glatiramer acetate (GA) therapies, using propensity score–matched cohorts from observational multiple sc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Clin Pract
Main Authors: Spelman, Tim, Kalincik, Tomas, Jokubaitis, Vilija, Zhang, Annie, Pellegrini, Fabio, Wiendl, Heinz, Belachew, Shibeshih, Hyde, Robert, Verheul, Freek, Lugaresi, Alessandra, Havrdová, Eva, Horáková, Dana, Grammond, Pierre, Duquette, Pierre, Prat, Alexandre, Iuliano, Gerardo, Terzi, Murat, Izquierdo, Guillermo, Hupperts, Raymond M.M., Boz, Cavit, Pucci, Eugenio, Giuliani, Giorgio, Sola, Patrizia, Spitaleri, Daniele L.A., Lechner-Scott, Jeannette, Bergamaschi, Roberto, Grand'Maison, François, Granella, Franco, Kappos, Ludwig, Trojano, Maria, Butzkueven, Helmut
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4828679/
https://ncbi.nlm.nih.gov/pubmed/27104064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/CPJ.0000000000000227
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados